Price
$1.78
Increased by +7.88%
Dollar volume (20D)
2.25 M
ADR%
4.97
Earnings report date
Aug 8, 2024
Shares float
51.53 M
Shares short
7.57 M [14.69%]
Shares outstanding
68.01 M
Market cap
112.21 M
Beta
-0.69
Price/earnings
N/A
20D range
1.57 1.83
50D range
1.57 2.56
200D range
1.57 21.28

Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases.

The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada.

It is also developing AMX0114 for other neurodegenerative diseases.

Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Jun 6, 24 -0.12
Decreased by -700.00%
-0.01
Decreased by -1.10 K%
Feb 22, 24 0.07
Increased by +110.77%
0.23
Decreased by -69.57%
Nov 9, 23 0.30
Increased by +132.61%
0.44
Decreased by -31.82%
Aug 10, 23 0.31
Increased by +133.33%
0.10
Increased by +210.00%
May 11, 23 0.02
Increased by +102.15%
-0.24
Increased by +108.33%
Mar 13, 23 -0.65
Increased by +84.34%
-0.82
Increased by +20.73%
Nov 10, 22 -0.92
Increased by +75.85%
-0.97
Increased by +5.15%
Aug 11, 22 -0.93 -0.87
Decreased by -6.90%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 24 88.64 M
Increased by +24.10%
-118.79 M
Decreased by -7.65 K%
Decreased by -134.01%
Decreased by -6.19 K%
Dec 31, 23 108.45 M
Increased by +395.54%
4.73 M
Increased by +111.08%
Increased by +4.36%
Increased by +102.24%
Sep 30, 23 102.69 M
Increased by +29.67 K%
20.89 M
Increased by +138.87%
Increased by +20.35%
Increased by +100.13%
Jun 30, 23 98.22 M
Increased by +N/A%
22.07 M
Increased by +140.83%
Increased by +22.47%
Decreased by N/A%
Mar 31, 23 71.43 M
Increased by +N/A%
1.57 M
Increased by +103.29%
Increased by +2.20%
Decreased by N/A%
Dec 31, 22 21.89 M
Increased by +N/A%
-42.70 M
Decreased by -50.66%
Decreased by -195.13%
Decreased by N/A%
Sep 30, 22 345.00 K
Increased by +21.05%
-53.76 M
Decreased by -132.29%
Decreased by -15.58 K%
Decreased by -91.89%
Jun 30, 22 0.00
Decreased by N/A%
-54.07 M
Decreased by -146.63%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY